| N | NP (%) | p Value | Mean TSS (95% CI) | |
| ETN + MTX week 12 responder | 171 | 69.0 | 0.440 | −0.53 (−0.880 to −0.185) |
| ETN + MTX week 24 responder | 20 | 80.0 | −1.35 (−2.472 to −0.234) | |
| ETN week 12 responder | 145 | 59.3 | 0.177 | −0.23 (−0.690 to 0.216) |
| ETN week 24 responder | 24 | 75.0 | −0.19 (−1.043 to 0.662) | |
| MTX week 12 responder | 133 | 48.1 | 0.037 | 0.64 (0.078 to 1.202) |
| MTX week 24 responder | 36 | 27.8 | 2.82 (−0.487 to 6.145) |
ETN, etanercept; MTX, methotrexate; NP, non-progressor defined by TSS ⩽0; TSS, total Sharp score.